160 related articles for article (PubMed ID: 30526175)
21. Polymorphous oligodendroglioma of Zülch revisited: a genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation.
Hewer E; Beck J; Murek M; Kappeler A; Vassella E; Vajtai I
Neuropathology; 2014 Aug; 34(4):323-32. PubMed ID: 24444336
[TBL] [Abstract][Full Text] [Related]
22. Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas.
Giantini Larsen A; Grannan BL; Lee CK; Koch MJ; Williams EA; Frosch MP; Cahill DP
J Neuropathol Exp Neurol; 2018 Jul; 77(7):549-554. PubMed ID: 29746652
[TBL] [Abstract][Full Text] [Related]
23. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography.
Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N
J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169
[TBL] [Abstract][Full Text] [Related]
24. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
Iwadate Y; Matsutani T; Hara A; Hirono S; Ikegami S; Kobayashi M; Ito D; Kawauchi D; Horiguchi K; Tamiya A; Higuchi Y
J Neurooncol; 2019 Jan; 141(1):205-211. PubMed ID: 30565028
[TBL] [Abstract][Full Text] [Related]
25. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
26. Pancytopaenia from a disseminated anaplastic oligodendroglioma.
Dawson TP
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):516-20. PubMed ID: 9460719
[TBL] [Abstract][Full Text] [Related]
27. Holocord oligodendroglioma with intracranial extension in a young adult: a case report and review of literature.
Cruz REH; De Roxas RC; Sales-Callangan CCA; Jamora RDG
CNS Oncol; 2018 Jan; 7(1):1-5. PubMed ID: 29390865
[TBL] [Abstract][Full Text] [Related]
28. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
[TBL] [Abstract][Full Text] [Related]
29. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
Sathornsumetee S; Cheunsuchon P; Sangruchi T
World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow metastases from anaplastic oligodendroglioma presenting with pancytopenia and hypogammaglobulinemia: a case report.
Cordiano V; Miserocchi F; Storti M
Tumori; 2011; 97(6):808-11. PubMed ID: 22322851
[TBL] [Abstract][Full Text] [Related]
31. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
[TBL] [Abstract][Full Text] [Related]
32. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
[TBL] [Abstract][Full Text] [Related]
33. [Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].
Xiong J; Liu Y; Li C; Zhu JJ; Ye ZR; Mao Y; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):445-50. PubMed ID: 19781190
[TBL] [Abstract][Full Text] [Related]
34. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
[TBL] [Abstract][Full Text] [Related]
35. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
[TBL] [Abstract][Full Text] [Related]
36. Breast metastases from oligodendroglioma: an unusual extraneural spread in two young women and a review of the literature.
Mazza E; Belli C; Terreni M; Doglioni C; Losio C; Cantore M; Mambrini A; Reni M
Crit Rev Oncol Hematol; 2013 Dec; 88(3):564-72. PubMed ID: 23953683
[TBL] [Abstract][Full Text] [Related]
37. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
38. Metastatic oligodendroglioma. Case report.
Monzani V; Rovellini A; Masini B; Cappricci E; Miserocchi G
J Neurosurg Sci; 1996; 40(3-4):239-41. PubMed ID: 9165433
[TBL] [Abstract][Full Text] [Related]
39. Treatment recommendations for anaplastic oligodendrogliomas that are codeleted.
Anderson MD; Gilbert MR
Oncology (Williston Park); 2013 Apr; 27(4):315-20, 322. PubMed ID: 23781695
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
